http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-033238-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
filingDate 2015-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_967285a2a937cbf64e494070af735d21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7565878751ea4217ef9f7be5a62dfcaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e99310a7c4f0a29166171bd9b0165f1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c21388da8f63e6998868b1f6d4182cd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b80e04bcd5a71bd43d37c4fcc1d02021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3f4f0606d87a317286fef21f60c1d5e
publicationDate 2019-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-033238-B1
titleOfInvention NEW THYENOPYRIMIDINE DERIVATIVES AS NIK INHIBITORS
abstract The invention relates to inhibitors of NF-κB-inducing kinase (NIK, also known as MAP3K14) of formula (I) in which all substituents are defined in the claims applicable to the treatment of diseases such as cancer. The present invention is also directed to pharmaceutical compositions containing such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases associated with NF-κB-inducing kinase.
priorityDate 2014-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012123522-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009158011-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID508367
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID419964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12603004
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID53859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412833013
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID454750
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID9020
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID360640
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID490926

Total number of triples: 34.